Lineage Cell Therapeutics, Inc. Common Stock (LCTX)
SBC to Revenue
38.75%
TTM · Retrieved:
LCTX SBC to Revenue
Current (TTM)38.75%retrieved
Current (TTM)38.75%retrieved
LCTX SBC/Revenue (0.00% → 38.75%)
Latest values, visible window
High-resolution chart · PNG
LCTX sbc to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SBC to Revenue |
|---|---|
| 32.6463% | |
| 53.4477% | |
| 51.8726% | |
| 29.1573% | |
| 90.3234% | |
| 288.0983% | |
| 242.2192% | |
| 381.4972% | |
| 219.4196% | |
| 353.0639% | |
| 436.0695% | |
| 228.909% | |
| 112.4735% | |
| 75.7594% | |
| 27.9584% | |
| 17.3548% | |
| 25.3777% | |
| 8.9453% | |
| 14.4399% | |
| 0% | |
| 9.8736% | |
| 0% | |
| 0% | |
| 49.5892% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |